How Ginkgo Bioworks Holdings, Inc. stacks up

DNA · against 1,327 other Healthcare companies

Overall

19/ 100

Near the bottom of its peers.

Ranked #1,266 of 1,328 · scores higher than 4% of peers

Bars: peers in each 10-point band of the overall score

44 peers with an overall score of 10–19, including DNA · Click a bar to see the companies

The four scores behind it

Overall = average of valuation, growth, profitability and safety percentile (categories without data are skipped)

Valuation#730 of 1,337Score 45 / 100 · beats 45%Growth#1,187 of 1,217Score 2 / 100 · beats 2%Profitability#1,156 of 1,336Score 13 / 100 · beats 13%Risk#1,138 of 1,373Higher relative risk · safety 17 · beats 17%

Ranking by overall score

Top 5 and the companies ranked around DNA

Rank	Company	Market cap	Overall	Valuation	Growth	Profitability	Risk
1	BB Biotech AGBBZA.DE · Europe	3.1B EUR (≈$3.4B)	100		100	100	0 / 2
2	Arbutus Biopharma CorporationABUS · US-listed	595M USD	97	96	98	99	0 / 2
2	Q32 Bio Inc.QTTB · US-listed	261M USD	97	93	—	98	0 / 2
4	Lakefront Biotherapeutics NVLKFT · US-listed	2.1B USD	96	96	99	93	0 / 2
4	Zealand Pharma A/SZEAL.CO · Europe	15.6B DKK (≈$2.3B)	96	96	99	96	0 / 2
⋯
1,255	OPKO Health, Inc.OPK · US-listed	1.3B USD	20	8	8	31	2 / 2
1,255	Arcus Biosciences, Inc.RCUS · US-listed	2.4B USD	20	8	8	7	1 / 2
1,255	Zymeworks Inc.ZYME · US-listed	2.2B USD	20	8	3	6	1 / 2
1,266	Lionco Pharmaceutical Group Co.,Ltd.603669.SS · China	3.7B CNY (≈$518M)	19	0	17	32	2 / 2
1,266	Ginkgo Bioworks Holdings, Inc.DNA · US-listed	725M USD	19	45	2	13	2 / 2
1,266	EyePoint, Inc.EYPT · US-listed	34M USD	19	33	0	1	1 / 2
1,266	Ionis Pharmaceuticals, Inc.IONS · US-listed	6.7B USD	19	8	30	20	2 / 2
1,270	Chengdu huasun technology group Inc. , LTD.000790.SZ · China	2.2B CNY (≈$308M)	18	0	3	32	1 / 2
1,270	Harbin Medisan Pharmaceutical Co., Ltd.002900.SZ · China	3.1B CNY (≈$440M)	18	0	6	27	1 / 2

Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score

Bringing the fundamentals into focus…